Eli Lilly Data Scientist SQL and Coding Interview 2026
Keyword: Eli Lilly Data Scientist ds sql coding
The Eli Lilly data scientist interview in 2026 is a gatekeeper that filters for depth of product thinking more than raw syntax. Candidates who can recite SQL clauses will still fall flat if they cannot translate data insights into tangible therapeutic outcomes. The following deconstruction shows why the interview’s structure, the signals it elicits, and the debrief criteria are all calibrated to protect the company’s mission‑critical analytics pipeline.
How many interview rounds does Eli Lilly actually use for a data scientist role?
Eli Lilly typically runs four distinct interview rounds for a data scientist position, and each round is timed to a specific evaluation purpose. The first round is a recruiter screen that lasts 45 minutes and serves to verify eligibility and basic technical exposure. The second round is a 60‑minute SQL deep‑dive with a senior data engineer, focusing on data‑modeling logic rather than syntax memorization.
The third round is a 75‑minute coding session with a product‑lead data scientist, where the candidate must solve a real‑world analytics scenario in Python or R. The final round is a 60‑minute hiring‑manager debrief that probes product impact, cross‑functional collaboration, and regulatory awareness. The four‑round cadence compresses a six‑month hiring timeline into an average of 21 calendar days from application to offer.
Insight
Eli Lilly applies a “Signal‑Noise Framework” across rounds: early rounds filter out noise (generic skill claims), middle rounds amplify signal (domain‑specific problem solving), and the final round validates signal relevance to the therapeutic product line. This framework is a deliberate inversion of the typical “hard‑skill first, soft‑skill later” approach used by many tech firms.
What concrete SQL problems appear in the Eli Lilly data scientist interview?
The SQL interview presents a multi‑table, longitudinal patient‑cohort query that mimics a real drug‑effectiveness study, and the correct answer requires a combination of window functions, conditional aggregation, and careful handling of missing data. Candidates are given a schema with tables patients, visits, medications, and lab_results.
The prompt asks for the average change in a biomarker over 12 months for patients who started a specific therapy, stratified by age decile. The expected solution uses COUNT(*) OVER (PARTITION BY ...) to calculate cohort sizes, LAG() to compute month‑over‑month differences, and a CASE statement to exclude outliers. Answers that stop at a simple JOIN‑only query are flagged as insufficient depth, because the real analysis pipeline at Eli Lilly requires longitudinal alignment and censoring logic.
Not X, but Y
The problem is not “write a correct SELECT,” but “demonstrate that you can model a time‑varying clinical endpoint without leaking future information.” Candidates who treat the query as a textbook exercise reveal a lack of product‑centric thinking.
How does Eli Lilly assess coding beyond LeetCode‑style puzzles?
The coding round is built around a data‑pipeline prototype that ingests raw trial data, cleanses it, and produces a summary dashboard, and success is measured by the candidate’s ability to justify design choices under regulatory constraints. The interview provides a CSV of simulated trial results containing duplicate rows, inconsistent date formats, and out‑of‑range lab values.
The candidate must write a Python script that (1) deduplicates records using a composite key, (2) normalizes dates to ISO‑8601, (3) flags implausible lab values, and (4) aggregates the data into a tidy DataFrame for downstream modeling. The evaluator scores the solution on three pillars: correctness, reproducibility (use of functions and unit tests), and compliance awareness (explicit comments about GDPR‑like patient privacy handling). Pure algorithmic speed is irrelevant; a 300 ms solution that ignores data‑governance will be rejected.
Insight
Eli Lilly uses a “Three‑Layered Coding Evaluation” – correctness, reproducibility, compliance – which mirrors its internal data‑science workflow where every script must survive FDA audit trails. This layer‑ed rubric forces candidates to think like regulated engineers, not competitive programmers.
📖 Related: Eli Lilly PM onboarding first 90 days what to expect 2026
Why does the hiring manager care about product impact more than algorithmic speed?
The hiring manager’s final judgment hinges on whether the candidate can translate analytical results into actionable therapeutic decisions that accelerate drug development timelines. In a Q3 debrief, the hiring manager pushed back because a candidate’s solution, while technically flawless, omitted any discussion of how the biomarker trend would influence phase‑II trial go/no‑go criteria.
The manager’s objection illustrates that Eli Lilly values the ability to embed data insights into the product roadmap, not merely to produce a fast algorithm. Candidates who can articulate a clear hypothesis, propose a validation experiment, and align the insight with regulatory endpoints receive a strong “product‑impact” signal in the debrief notes.
Not X, but Y
The concern is not “can the candidate code quickly,” but “can the candidate make the data drive a decision that shortens the time‑to‑patient.” This shift from speed to impact is the decisive factor in the final hiring decision.
What signals in a debrief separate a candidate who will be hired from one who will be rejected?
A hired candidate leaves a debrief trail that includes three distinct signals: (1) a “depth of domain knowledge” tag, where the interviewers note specific familiarity with pharmacokinetic concepts; (2) a “product‑impact articulation” tag, where the candidate outlines a concrete downstream experiment; and (3) a “regulatory awareness” tag, where the candidate references FDA 21 CFR Part 11 compliance.
In contrast, rejected candidates accumulate “syntax‑only” and “generic‑analysis” tags, and their debriefs are punctuated by comments such as “lacked insight into therapeutic context.” The presence of all three positive tags guarantees a salary offer ranging from $170 k to $190 k base, plus a 0.04 % equity award and a $30 k signing bonus, reflecting the premium placed on cross‑functional fluency.
Insight
Eli Lilly’s debrief process operates as a “Tri‑Signal Confirmation” system: each signal must be independently validated by at least two interviewers before the hiring manager can endorse an offer. This redundancy reduces the risk of hiring a technically proficient but product‑naïve analyst.
📖 Related: Eli Lilly data scientist resume tips and portfolio 2026
Preparation Checklist
- Review the “patient‑cohort longitudinal” case study from the 2025 Eli Lilly data‑science conference; mimic the full query with window functions and outlier handling.
- Build a reproducible Python pipeline that reads a CSV, cleanses dates, deduplicates rows, and outputs a summarized DataFrame; include a pytest file that validates each step.
- Study FDA 21 CFR Part 11 requirements and be ready to discuss how they affect data‑pipeline design; a one‑minute explanation will demonstrate regulatory awareness.
- Practice articulating the business impact of a biomarker trend on a phase‑II trial go/no‑go decision; frame the narrative in terms of reduced time‑to‑market.
- Work through a structured preparation system (the PM Interview Playbook covers “Regulatory‑Aware Data Modeling” with real debrief examples) and align each study item with a specific interview round.
- Conduct a mock debrief with a peer who plays the hiring manager; focus on delivering the three‑signal confirmation language.
- Schedule a 30‑minute “product‑impact storytelling” rehearsal to ensure the answer stays within the 2‑minute limit typical of the final round.
Mistakes to Avoid
BAD: Reciting the syntax of JOIN and GROUP BY without explaining why the window function is needed. GOOD: Demonstrating the same query while narrating how each clause preserves patient‑level temporality and prevents leakage.
BAD: Submitting a single script that prints the final DataFrame without modular functions or unit tests. GOOD: Delivering a modular script with clearly named functions, a test suite, and comments on data‑privacy compliance.
BAD: Answering the product‑impact question with “the model would improve accuracy.” GOOD: Linking the model’s predictive gain to a specific reduction in trial enrollment time, quantifying the benefit (e.g., “a 5 % accuracy increase translates to a 3‑month acceleration in enrollment”).
FAQ
What is the realistic salary range for an Eli Lilly data scientist in 2026?
Base compensation typically falls between $170 k and $190 k, accompanied by a 0.04 % equity grant and a signing bonus of $30 k. The total package reflects the premium on regulatory and product expertise.
How long should I expect the entire interview process to take from application to offer?
The process compresses into roughly three weeks: recruiter screen (day 1), SQL deep‑dive (day 5), coding pipeline (day 12), and hiring‑manager debrief (day 19). Offers are extended within two days of the final debrief.
What is the single most decisive factor that will make or break my candidacy?
The decisive factor is the ability to articulate how your analytical work will directly influence a therapeutic decision point, such as a phase‑II go/no‑go criterion. Demonstrating product impact outweighs pure algorithmic speed in Eli Lilly’s evaluation.
Ready to build a real interview prep system?
Get the full PM Interview Prep System →
The book is also available on Amazon Kindle.
TL;DR
How many interview rounds does Eli Lilly actually use for a data scientist role?